ASCENTAGE PHARMA GR-ADR (AAPG) Stock Income Statement
NASDAQ:AAPG - Nasdaq - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 980.65M | 221.98M | 209.71M | 27.91M | 12.45M | |||
| Minority Interest Expense | 247.00K | 75.00K | N/A | N/A | N/A | |||
| Cost Of Goods | 29.09M | 30.54M | 22.00M | 3.33M | 1.97M | |||
| Gross Profit | 951.57M | 191.44M | 187.71M | 24.58M | 10.48M | |||
| Operating Expenses | 1.33B | 1.07B | 1.04B | 917.83M | 698.24M | |||
| Research and Development | 913.81M | 706.97M | 743.10M | 766.49M | 564.57M | |||
| Selling, General, and Administrative Expenses | 331.77M | 376.46M | 328.02M | 191.26M | 130.34M | |||
| Operating Income | -374.17M | -874.04M | -852.93M | -893.25M | -687.75M | |||
| Interest Income/Expense | -21.03M | -58.83M | -36.30M | 61.00M | 12.31M | |||
| Non Recurring Items | -50.00K | 4.00K | 2.07M | N/A | N/A | |||
| Income Before Taxes | -395.25M | -932.86M | -887.17M | -832.25M | -675.45M | |||
| Income Tax | 10.43M | -7.15M | -4.25M | -49.83M | 2.16M | |||
| Net Income | -405.43M | -925.64M | -882.92M | -782.42M | -677.61M | |||
| EBITDA | -281.00M | -796.73M | -791.46M | -864.92M | -660.33M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.81 | -11.76 | -12.01 | -11.02 | -11.25 | |||
| Statistics | ||||||||
| Gross Profit Margin | 97.03% | 86.24% | 89.51% | 88.08% | 84.21% | |||
| Profit Margin | -41.34% | -416.98% | -421.02% | -2803.38% | -5442.62% | |||
| Operating Profit Margin | -38.16% | -393.74% | -406.72% | -3200.45% | -5524.14% | |||
All data in CNY